News
Important Only
Bitgo Holdings Inc - Estimated IPO Price Between $15.00 And $17.00 Per Share - SEC Filing
Jan 12 (Reuters) - BITGO HOLDINGS INC - ESTIMATED IPO PRICE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILINGBITGO HOLDINGS INC - TO OFFER 11.8 MILLION SHARES OF CLASS A COMMON STOCK IN IPO - SEC FILINGBITGO HOLDINGS, INC - CO OFFERING 11 MILLION SHARES OF CLASS A COMMON STOCKBITGO HOLDINGS, INC - ...Reuters
Mon, Jan 12
Pegasystems Inc - Commits To Organizational Changes Impacting Consulting - SEC Filing
Jan 12 (Reuters) - Pegasystems Inc PEGA.O:PEGASYSTEMS INC - COMMITS TO ORGANIZATIONAL CHANGES IMPACTING CONSULTING - SEC FILINGPEGASYSTEMS INC - HAS BEGUN ROLE ELIMINATIONS AND REORGANIZATION WITH NOTIFICATIONS BY Q1 2026 - SEC FILINGPEGASYSTEMS INC - EXPECTS $13 MILLION CHARGE FOR SEVERANCE AND BEN...Reuters
Mon, Jan 12
Lyra Therapeutics Inc - Terminates CEO Maria Palasis And CFO Jason Cavalier - SEC Filing
Jan 12 (Reuters) - Lyra Therapeutics Inc LYRA.O:LYRA THERAPEUTICS INC - TERMINATES CEO MARIA PALASIS AND CFO JASON CAVALIER - SEC FILINGLYRA THERAPEUTICS INC - PALASIS AND CAVALIER TO CONTINUE AS PRINCIPAL OFFICERS - SEC FILINGReuters
Mon, Jan 12
Ultragenyx Provides Financial And Business Updates At J.P. Morgan Annual Healthcare Conference
Jan 12 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX PROVIDES FINANCIAL AND BUSINESS UPDATES AT J.P. MORGAN ANNUAL HEALTHCARE CONFERENCE2025 REVENUE EXCEEDS GUIDANCE AT $672 MILLION-$674 MILLIONCASH AND INVESTMENTS ABOUT $735 MILLION AS OF DEC 31, 2025FY2025 REVENUE VIEW $655.6 MILLION...Reuters
Mon, Jan 12
Kustom Entertainment, Inc. Completes The Divestiture Of Its Nobility Healthcare Subsidiary Sharpens Its Focus On $100 Billion Live Entertainment And Online Ticketing Markets
Jan 12 (Reuters) - Kustom Entertainment Inc KUST.O:KUSTOM ENTERTAINMENT, INC. COMPLETES THE DIVESTITURE OF ITS NOBILITY HEALTHCARE SUBSIDIARY; SHARPENS ITS FOCUS ON $100 BILLION LIVE ENTERTAINMENT AND ONLINE TICKETING MARKETSReuters
Mon, Jan 12
Kelly Services Adopts Stockholder Rights Plan
Jan 12 (Reuters) - Kelly Services Inc KELYA.O:KELLY SERVICES ADOPTS STOCKHOLDER RIGHTS PLANKELLY SERVICES INC - ON JAN 9, TERENCE E. ADDERLEY TRUST TO SELL 92.2% OF CLASS B STOCKKELLY SERVICES INC - TO ISSUE RIGHTS FOR CLASS A AND B SHARESKELLY SERVICES INC - RIGHTS EXPIRE JANUARY 10, 2027KELLY SERV...Reuters
Mon, Jan 12
AGM Holdings Signs Strategic Memorandum Of Understanding To Enter The New Arena Of Real-World Asset (RWA) Tokenization
Jan 12 (Reuters) - AGM Group Holdings Inc AGMH.O:AGM HOLDINGS SIGNS STRATEGIC MEMORANDUM OF UNDERSTANDING TO ENTER THE NEW ARENA OF REAL-WORLD ASSET (RWA) TOKENIZATIONReuters
Mon, Jan 12
Selectquote Secures New $415 Million Credit Facility Comprised Of $325 Million Term Loan With Pathlight Capital Alongside $90 Million Revolving Credit Facility With Umb Bank
Jan 12 (Reuters) - SelectQuote Inc SLQT.N:SELECTQUOTE SECURES NEW $415 MILLION CREDIT FACILITY COMPRISED OF $325 MILLION TERM LOAN WITH PATHLIGHT CAPITAL ALONGSIDE $90 MILLION REVOLVING CREDIT FACILITY WITH UMB BANKReuters
Mon, Jan 12
Glucose monitor maker Dexcom's prelim Q4 revenue beats expectations on G7 15 Day launch
OverviewGlucose biosensing firm's preliminary Q4 revenue rises 13%, beating analyst expectationsFiscal 2025 revenue grows 16% yr/yr, driven by sensor technology launchCompany anticipates 11-13% revenue growth in 2026, driven by sensor volume growthOutlookDexcom anticipates 2026 revenue of $5.16 ...Reuters
Mon, Jan 12
Emergent Biosolutions Announces $100 Million Paydown Of Term Loan Principal, A Significant Step Achieved Toward Its Multi-Year Transformation
Jan 12 (Reuters) - Emergent BioSolutions Inc EBS.N:EMERGENT BIOSOLUTIONS ANNOUNCES $100 MILLION PAYDOWN OF TERM LOAN PRINCIPAL, A SIGNIFICANT STEP ACHIEVED TOWARD ITS MULTI-YEAR TRANSFORMATIONReuters
Mon, Jan 12
IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Jan 12 (Reuters) - Cabaletta Bio Inc CABA.O:IND AMENDMENT CLEARANCE OBTAINED FOR CLINICAL MANUFACTURING OF RESE-CEL FROM CABALETTA BIO USING CELLARES' AUTOMATED PLATFORMSReuters
Mon, Jan 12
Urban Outfitters Inc - Reports 9% Increase In Net Sales For Two Months Ended December 31, 2025
Jan 12 (Reuters) - Urban Outfitters Inc URBN.O:URBAN OUTFITTERS INC - REPORTS 9% INCREASE IN NET SALES FOR TWO MONTHS ENDED DECEMBER 31, 2025URBAN OUTFITTERS INC - REPORTS 11% INCREASE IN NET SALES FOR 11 MONTHS ENDED DECEMBER 31, 2025Reuters
Mon, Jan 12
GeneDx prelim Q4 revenue beats expectations
OverviewGenomics leader's preliminary Q4 2025 revenue beats analyst expectationsExome and genome revenue grew 54% yr/yr for full year 2025Company issues 2026 guidance with expected revenue of $540 to $555 mlnOutlookGeneDx expects full-year 2026 revenue between $540 mln and $555 mlnCompany antici...Reuters
Mon, Jan 12
iRhythm Technologies Inc Anticipate Fy25 Revenue To Exceed High End Of Previously Stated Guidance Range Of $740 Million Provided In October 2025
Jan 12 (Reuters) - iRhythm Technologies Inc IRTC.O:: ANTICIPATE FY25 REVENUE TO EXCEED HIGH END OF PREVIOUSLY STATED GUIDANCE RANGE OF $740 MILLION PROVIDED IN OCTOBER 2025: FOR FULL YEAR 2026, EXPECT REVENUE OF ABOUT $870 MILLION TO $880 MILLIONFY2026 REVENUE VIEW $862.7 MILLION -- LSEG IBES DATAFY...Reuters
Mon, Jan 12
